Nvidia Up, Campbell's Gains, Eli Lilly Rises as 30% Weight Loss Sets High Bar for Obesity Drug...

Why It Matters

Nvidia’s deals accelerate its addressable market in AI memory and industrial robotics, underpinning further demand for chips; Campbell’s pullback on buybacks and persistent margin pressure signal challenged growth and shareholder returns in legacy consumer names. Eli Lilly’s 30% weight‑loss data raises the efficacy bar and could shift market share and pricing dynamics across the booming obesity‑drug sector.

Summary

Nvidia climbed about 1% after announcing a multi‑year pact with SK Hynix to design next‑generation AI memory chips and an expanded alliance with Hyundai to commercialize physical AI and robotics, with CEO Jensen Huang framing the tech selloff as a buying opportunity. Campbell Soup swung after mixed results — revenue slightly missed while adjusted EPS beat — but the company cut share repurchases and offered no dividend boost, leaving margins pressured and prompting talk of an S&P 500 replacement. Eli Lilly surged after presenting data showing its next‑generation obesity drug can deliver roughly 30% body‑weight loss over about two years, outpacing peers and highlighting lower side‑effect and convenience claims. Overall market movers reflected a tech‑led AI narrative, legacy consumer margin strains, and intensifying competition in the obesity‑drug market.

Original Description

On this episode of Stock Movers:

- Nvidia (NVDA) shares are up after Chief Executive Officer Jensen Huang called a global tech stocks selloff a buying opportunity, saying the buildout of artificial intelligence has just begun.

- Campbell's (CPB) shares gain after the canned soup maker reported adjusted earnings per share for the third quarter that beat the average analyst estimate.

- Eli Lilly (LLY) shares rise after the company presented data showing its next-generation shot, retatrutide, can help patients lose 30% of their body weight over about two years.

See omnystudio.com/listener (https://omnystudio.com/listener) for privacy information.

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.

Check out more episodes of Stock Movers: https://www.youtube.com/playlist?list=PLe4PRejZgr0NxhJreY_kjMBdW8cvmNauU

Visit us: https://www.bloomberg.com/podcasts

Follow Bloomberg Podcasts on Twitter: https://twitter.com/podcasts

Visit our other YouTube channels:

Bloomberg Television: https://www.youtube.com/@markets

Bloomberg Originals: https://www.youtube.com/bloomberg

Quicktake: https://www.youtube.com/@BloombergQuicktake

For coverage on news, markets and more: http://www.bloomberg.com/video

#Stocks #Markets #Finance #Investing #Podcast #Bloomberg

Nvidia Up, Campbell's Gains, Eli Lilly Rises as 30% Weight Loss Sets High Bar for Obesity Drug Race